Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

The identification of H3F3A mutation in giant cell tumour of the clivus and the histological diagnostic algorithm of other clival lesions permit the differential diagnosis in this location

Authors: Federica Scotto di Carlo, Giuseppina Divisato, Maurizio Iacoangeli, Teresa Esposito, Fernando Gianfrancesco

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Giant Cell Tumour of Bone (GCT) is a locally aggressive primary bone tumour that usually occurs at the epiphyses of the long bones of the appendicular skeleton with a tendency to recurrence. Recurrent somatic H3F3A mutations have been described in 92% of GCT cases. GCTs involving the Clivus are extremely rare lesions and less than 15 cases are described in the literature. They represent a surgery challenge and are easily misdiagnosed. Our aim was to reveal if the genetic bases underlying Clival GCTs were the same of GCTs of long bones to improve the diagnosis and treatment.

Methods

The targeted somatic sequencing of GCT-related genes (H3F3A, H3F3B, IDH1, IDH2 and ZNF687) was performed on Clival GCT biopsies of two different cases. Histological analyses on the same tissues were used to detect the neoplastic population and its expression profile.

Results

Sanger sequencing revealed that both patients were positive for the p.Gly34Trp mutation in the H3F3A gene. Immunofluorescence assay using monoclonal antibody, specifically detecting the mutant H3.3, highlighted that the mutation only involved the mononuclear cell population and not the multinucleated giant cells. Moreover, immunohistochemistry assay showed that RANKL was highly expressed by the stromal cells within Clival GCT, mimicking what happens in GCT of the long bones. In addition, systematic literature review allowed us to generate a histology-based diagnostic algorithm of the most common clival lesions.

Conclusions

We conclude that the Clival GCT is genetically defined by somatic mutation in the H3F3A gene, linking it to the GCT of long bones. The similarity with GCTs of long bones let us to hypothesize the utility of Denosumab therapy (already effective for GCTs) in these surgically challenging cases. Moreover, H3F3A genetic screening can be combined to the histological analysis to differentiate GCTs from morphologically similar giant cell-rich sarcomas, while the histological diagnostic algorithm could help the differential diagnosis of other clival lesions.
Literature
1.
Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumour of bone. J Bone Joint Surg Am. 1987;69:106–14.CrossRefPubMed
2.
Morgan T, Atkins GJ, Trivett MK, Johnson SA, Kansara M, Schlicht SL, et al. Molecular profiling of giant cell tumour of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB. Am J Pathol. 2005;167:117–28.CrossRefPubMedPubMedCentral
3.
Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, Van Loo P, et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumour of bone. Nat Genet. 2013;45:1479–82.CrossRefPubMed
4.
Presneau N, Baumhoer D, Behjati S, Pillay N, Tarpey P, Campbell PJ, et al. Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics. J Pathol Clin Res. 2015;1:113–23.CrossRefPubMedPubMedCentral
5.
Cleven AH, Höcker S, Briaire-de Bruijn I, Szuhai K, Cleton-Jansen AM, Bovée JV. Mutation analysis of H3F3A and H3F3B as a diagnostic tool for Giant cell tumour of bone and Chondroblastoma. Am J Surg Pathol. 2015;39:1576–83.CrossRefPubMed
6.
Divisato G, Formicola D, Esposito T, Merlotti D, Pazzaglia L, Del Fattore A, et al. ZNF687 mutations in severe Paget disease of bone associated with Giant cell tumour. Am J Hum Genet. 2016;98:275–86.CrossRefPubMedPubMedCentral
7.
Divisato G, Scotto di Carlo F, Pazzaglia L, Rizzo R, Coviello DA, Benassi MS, et al. The distinct clinical features of Giant cell tumour of bone in pagetic and non-pagetic patients are associated with genetic, biochemical and histological differences. Oncotarget. 2017; https://​doi.​org/​10.​18632/​oncotarget.​18670.
8.
Gouin F, Dumaine V. French Sarcoma and Bone tumor study groups GSF-GETO. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French sarcoma and bone tumor study groups). Orthop Traumatol Surg Res. 2013;99:S313–8.CrossRefPubMed
9.
Gaston CL, Grimer RJ, Parry M, Stacchiotti S, Dei Tos AP, Gelderblom H, et al. Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone. Clin Sarcoma Res. 2016;6:15.CrossRefPubMedPubMedCentral
10.
Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol. 2010;11:275–80.CrossRefPubMed
11.
Wülling M, Engels C, Jesse N, Werner M, Delling G, Kaiser E. The nature of giant cell tumour of bone. J Cancer Res Clin Oncol. 2001;127:467–74.CrossRefPubMed
12.
Goldenberg RR, Campbell CJ, Bonfiglio M. Giant-cell tumour of bone. An analysis of two hundred and eighteen cases. J Bone Joint Surg Am 1970;52:619–664.
13.
Larsson SE, Lorentzon R, Boquist L. Giant-cell tumour of bone. A demographic, clinical, and histopathological study of all cases recorded in the Swedish Cancer registry for the years 1958 through 1968. J Bone Joint Surg Am. 1975;57:167–73.CrossRefPubMed
14.
Bertoni F, Unni KK, Beabout JW, Ebersold MJ. Giant cell tumour of the skull. Cancer. 1992;70:1124–32.CrossRefPubMed
15.
Sasagawa Y, Tachibana O, Shiraga S, Takata H, Kinoshita E, Nojima T, et al. Secondary malignant giant cell tumour of the clivus: case report. Clin Neurol Neurosurg. 2012;114:786–8.CrossRefPubMed
16.
Mahale A, K V N D, Pai M, Poornima V, Sahu KKMRI. Sequence and characteristic features in 'giant cell tumour' of clivus. J Clin Diagn Res. 2013;7:1197–200.PubMedPubMedCentral
17.
Roy S, Joshi NP, Sigamani E, Malik A, Sharma MC, Mohanti BK, et al. Clival giant cell tumour presenting with isolated trigeminal nerve involvement. Eur Arch Otorhinolaryngol. 2013;270:1167–71.CrossRefPubMed
18.
Iacoangeli M, Di Rienzo A, Re M, Alvaro L, Nocchi N, Gladi M, et al. Endoscopic endonasal approach for the treatment of a large clival giant cell tumour complicated by an intraoperative internal carotid artery rupture. Cancer Manag Res. 2013;5:21–4.CrossRefPubMedPubMedCentral
19.
Agrawal A, Gali R, Shanthi V, Ramakrishna BA, Mohan KV. Giant cell tumour of the clivus with presence of epithelioid histiocytes. Asian J Neurosurg. 2014;9:48–9.CrossRefPubMedPubMedCentral
20.
Zhao J, Qian T, Zhi Z, Li Q, Kang L, Wang J, et al. Giant cell tumour of the clivus: a case report and review of the literature. Oncol Lett. 2014;8:2782–6.CrossRefPubMedPubMedCentral
21.
Le J, Chaiyasate K, Donev K, Fahim DK. A rare case of giant cell tumour involving the clivus resected through Le fort I osteotomy and median maxillotomy. Surg Neurol Int. 2015;6:26.CrossRefPubMedPubMedCentral
22.
23.
Inoue A, Ohnishi T, Kohno S, Nishikawa M, Nishida N, Ohue S. Role of Denosumab in endoscopic Endonasal treatment for juvenile Clival Giant cell tumour: a case report and review of the literature. World Neurosurg. 2016;91:674.e1–6.CrossRef
24.
Patibandla MR, Thotakura AK, Rao MN, Addagada GC, Nukavarapu MC, Panigrahi MK, et al. Clival giant cell tumour - a rare case report and review of literature with respect to current line of management. Asian J Neurosurg. 2017;12:78–81.CrossRefPubMedPubMedCentral
25.
Zorlu F, Selek U, Soylemezoglu F, Oge K. Malignant giant cell tumor of the skull base originating from clivus and sphenoid bone. J Neuro-Oncol. 2006;76:149–52.CrossRef
26.
Gupta R, Mohindra S, Mahore A, Mathuriya SN, Radotra BD. Giant cell tumour of the clivus. Br J Neurosurg. 2008;22:447–9.CrossRefPubMed
27.
Lüke J, von Baer A, Schreiber J, Lübbehüsen C, Breining T, Mellert K, et al. H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant. Histopathology. 2017;71:125–33.CrossRefPubMed
28.
Kato Kaneko M, Liu X, Oki H, Ogasawara S, Nakamura T, Saidoh N, et al. Isocitrate dehydrogenase mutation is frequently observed in giant cell tumour of bone. Cancer Sci. 2014;105:744–8.CrossRefPubMedPubMedCentral
29.
Dahlin DC. Caldwell lecture. Giant cell tumor of bone: highlights of 407 cases. AJR Am J Roentgenol. 1985;144:955–60.CrossRefPubMed
30.
Picci P, Manfrini M, Fabbri N, Gambarotti M, Vanel D. Atlas of Musculoskeletal Tumors and Tumorlike Lesions. Switzerland: Springer International Publishing; 2014.CrossRef
31.
Potter GD, McClennan BL. Malignant giant cell tumor of the sphenoid bone and its differential diagnosis. Cancer. 1970;25:167–70.CrossRefPubMed
32.
Doshi R, Chaudhari AB, Thomson G. Giant cell tumor of the sphenoid bone. Can J Neurol Sci. 1977;4:213–6.CrossRefPubMed
33.
Wilbur AC, Choi KH, Tan WS, Jafar JJ, Spigos DG. Giant cell tumor of the sphenoid bone mimicking a pituitary tumor. AJNR Am J Neuroradiol. 1986;7:361–2.PubMed
34.
Weber AL, Hug EB, Muenter MW, Curtin HD. Giant-cell tumors of the sphenoid bone in four children: radiological, clinical, and pathological findings. Skull Base Surg. 1997;7:163–73.CrossRefPubMedPubMedCentral
35.
36.
Krishnan G, Narendra K, Sundhar K. Aggressive Osteoclastoma of sphenoid sinus: a rare surgical case report. Otorhinolaryngology clinics - An International Journal. 2016;8:68–71.
37.
Goto Y, Furuno Y, Kawabe T, Ohwada K, Tatsuzawa K, Sasajima H, et al. Treatment of a skull-base giant cell tumor with endoscopic endonasal resection and denosumab: case report. J Neurosurg. 2017;126:431–4.CrossRefPubMed
38.
Motomochi M, Handa Y, Makita Y, Hashi K. Giant cell tumor of the skull. Surg Neurol. 1985;23:25–30.CrossRefPubMed
39.
Büter JJ, Chilla R. Giant cell tumor of the temporal bone (osteoclastoma). Eur Arch Otorhinolaryngol. 1997;254:298–300.CrossRefPubMed
40.
Tsai Y-F, Liang-Kong C, Su C-T, Lee C-C, Wai C-P, Chen S-Y. Giant cell tumor of the Skull Base: a case report. Chin J Radiol. 2000;25:223–7.
41.
42.
Hsu S-W, Hueng D-Y, Lin H-C, Liu M-Y, Ma H-I, Hsia C-C. Giant cell tumor of the temporal bone. Formosan Journal of Surgery. 2013;46:30–2.CrossRef
43.
Billingsley JT, Wiet RM, Petruzzelli GJ, Byrne R. A locally invasive giant cell tumor of the skull base: case report. J Neurol Surg Rep. 2014;75:e175–9.CrossRefPubMedPubMedCentral
44.
Byun JH, Park KB, Ko JS, Ahn SK. Giant cell tumor of infratemporal Fossa and mandibular condyle: a case report. J Int Adv Otol. 2015;11:88–91.CrossRefPubMed
45.
Tamura R, Miwa T, Shimizu K, Mizutani K, Tomita H, Yamane N, et al. Giant cell tumor of the skull: review of the literature. J Neurol Surg A Cent Eur Neurosurg. 2016;77:239–46.PubMed
46.
Sang WH, Ha Young C. Malignant Giant cell tumor of the skull. J Korean Neurosurg Soc. 2004;36:324–7.
47.
Lu ZH, Yao ZW. Giant cell tumour of the posterior cranial fossa: a case report. Br J Radiol. 2011;84:e206–9.CrossRefPubMed
48.
Modkovski R, Elliott R, Rubin B, Zagzag D, Jafar J, Mikolaenko I. Giant cell tumor of the occipital bone and secondary aneurysmal bone cyst: case report and review of literature. The internet. J Neurosurg. 2009;7:1–7.
49.
Uslu GH, Canyilmaz E, Yöney A, Aydin S, Sahbaz A, Sari A. Giant cell tumor of the occipital bone: a case report and review of the literature. Oncol Lett. 2014;8:151–4.CrossRefPubMedPubMedCentral
50.
Tang PH, Mettu P, Maltry AC, Harrison AR, Mokhtarzadeh A. Giant cell tumor of the frontal bone presenting as an orbital mass. Ophthalmol Ther. 2017;6:215–20.CrossRefPubMedPubMedCentral
51.
Alzarei A, Assiri M, R NB, Aljoraebi W, Sumaily I. Giant cell tumor of the frontal sinus: case report. International Journal of Otorhinolaryngology and Head and Neck Surgery. 2017;3:725–7.CrossRef
52.
Erdem E, Angtuaco EC, Van Hemert R, Park JS, Al-Mefty O. Comprehensive review of intracranial chordoma. Radiographics. 2003;23:995–1009.CrossRefPubMed
53.
Chambers KJ, Lin DT, Meier J, Remenschneider A, Herr M, Gray ST. Incidence and survival patterns of cranial chordoma in the United States. Laryngoscope. 2014;124:1097–102.CrossRefPubMed
54.
Korten AG, ter Berg HJ, Spincemaille GH, van der Laan RT, Van de Wel AM. Intracranial chondrosarcoma: review of the literature and report of 15 cases. J Neurol Neurosurg Psychiatry. 1998;65:88–92.CrossRefPubMedPubMedCentral
55.
Brackmann DE, Teufert KB. Chondrosarcoma of the skull base: long-term follow-up. Otol Neurotol. 2006;27:981–91.CrossRefPubMed
56.
Almefty K, Pravdenkova S, Colli BO, Al-Mefty O, Gokden M. Chordoma and chondrosarcoma: similar, but quite different, skull base tumors. Cancer. 2007;110:2457–67.CrossRefPubMed
57.
Rosenberg AE, Nielsen GP, Keel SB, Renard LG, Fitzek MM, Munzenrider JE, et al. Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol. 1999;23:1370–8.CrossRefPubMed
58.
NG HK, Wong AT. Expression of epithelial and extracellular matrix protein markers in meningiomas. Histopathology. 1993;22:113–25.CrossRefPubMed
59.
Kawase T, Shiobara R, Ohira T, Toya S. Developmental patterns and characteristic symptoms of petroclival meningiomas. Neurol Med Chir (Tokyo). 1996;36:1–6.CrossRef
60.
Liu Y, Sturgis CD, Bunker M, Saad RS, Tung M, Raab SS, Silverman JF. Expression of cytokeratin by malignant meningiomas: diagnostic pitfall of cytokeratin to separate malignant meningiomas from metastatic carcinoma. Mod Pathol. 2004;17:1129–33.CrossRefPubMed
61.
Guo Z, Hu K, Zhao B, Bian E, Ni S, Wan J. Osteosarcoma of the skull base: an analysis of 19 cases and literature review. J Clin Neurosci. 2017;44:133–42.CrossRefPubMed
62.
Yoshida H, Adachi H, Hamada Y, Aki T, Yumoto T, Morimoto K, et al. Osteosarcoma. Ultrastructural and immunohistochemical studies on alkaline phosphatase-positive tumor cells constituting a variety of histologic types. Acta Pathol Jpn. 1988;38:325–38.PubMed
63.
Karras CL, Abecassis IJ, Abecassis ZA, Adel JG, Bit-Ivan EN, Chandra RK, et al. Clival ectopic pituitary adenoma mimicking a Chordoma: case report and review of the literature. Case Rep Neurol Med. 2016;2016:8371697.PubMedPubMedCentral
64.
Grau S, Schueller U, Weiss C, Tonn JC. Primary meningeal T-cell lymphoma at the clivus mimicking a meningioma. World Neurosurg. 2010;74:513–6.CrossRefPubMed
65.
Kalwani N, Remenschneider AK, Faquin W, Ferry J, Holbrook EH. Plasmacytoma of the Clivus presenting as bilateral sixth nerve palsy. J Neurol Surg Rep. 2015;76:e156–9.CrossRefPubMedPubMedCentral
66.
Boyd SD, Natkunam Y, Allen JR, Warnke RA. Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results. Appl Immunohistochem Mol Morphol. 2013;21:116–31.PubMedPubMedCentral
67.
Pallini R, Sabatino G, Doglietto F, Lauretti L, Fernandez E, Maira G. Clivus metastases: report of seven patients and literature review. Acta Neurochir. 2009;151:291–6.CrossRefPubMed
68.
Deconde AS, Sanaiha Y, Suh JD, Bhuta S, Bergsneider M, Wang MB. Metastatic disease to the clivus mimicking clival chordomas. J Neurol Surg B Skull Base. 2013;74:292–9.CrossRefPubMedPubMedCentral
69.
Yu WYH, Tierney LM. HCC without cirrhosis metastasizing to the clivus. Int Canc Conf J. 2015;4:181.CrossRef
70.
Amary F, Berisha F, Ye H, Gupta M, Gutteridge A, Baumhoer D, et al. H3F3A (histone 3.3) G34W immunohistochemistry: a reliable marker defining benign and malignant Giant cell tumor of bone. Am J Surg Pathol. 2017;41:1059–68.CrossRefPubMedPubMedCentral
71.
Righi A, Mancini I, Gambarotti M, Picci P, Gamberi G, Marraccini C, et al. Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone. Hum Pathol. 2017;68:128–35.CrossRefPubMed
72.
Kervarrec T, Collin C, Larousserie F, Bouvier C, Aubert S, Gomez-Brouchet A, et al. H3F3 mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach. Mod Pathol. 2017;30:393–406.CrossRefPubMed
73.
Ralston SH, Layfield R. Pathogenesis of Paget disease of bone. Calcif Tissue Int. 2012;91:97–113.CrossRefPubMed
74.
Pazzaglia L, Conti A, Chiechi A, Novello C, Magagnoli G, Astolfi A, et al. Differential gene expression in classic giant cell tumours of bone: tenascin C as biological risk factor for local relapses and metastases. Histopathology. 2010;57:59–72.CrossRefPubMed
75.
Aragão Mdo S, Piva MR, Nonaka CF, Freitas Rde A, de Souza LB, Pinto LP. Central giant cell granuloma of the jaws and giant cell tumor of long bones: an immunohistochemical comparative study. J Appl Oral Sci. 2007;15:310–6.CrossRefPubMed
76.
Bertoni F, Bacchini P, Staals EL. Malignancy in giant cell tumor of bone. Cancer. 2003;97:2520–9.CrossRefPubMed
77.
Gray H, Carter HV. Anatomy of the human body. 20th ed. Lea & Febiger; 1918
Metadata
Title
The identification of H3F3A mutation in giant cell tumour of the clivus and the histological diagnostic algorithm of other clival lesions permit the differential diagnosis in this location
Authors
Federica Scotto di Carlo
Giuseppina Divisato
Maurizio Iacoangeli
Teresa Esposito
Fernando Gianfrancesco
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4291-z

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue

Research article

Expression of the glucagon-like peptide-1 receptor and its role in regulating autophagy in endometrial cancer

Research article

A systematic review of clinic and community intervention to increase fecal testing for colorectal cancer in rural and low-income populations in the United States – How, what and when?

Case report

Case report: primary resistance to osimertinib in erlotinib-pretreated lung adenocarcinoma with EGFR T790 M mutation

Research article

Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma

Research article

Oral cancer incidence in Shanghai ---- a temporal trend analysis from 2003 to 2012

Research article

Oncogenic potential of N-terminal deletion and S45Y mutant β-catenin in promoting hepatocellular carcinoma development in mice
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits